A detailed history of Douglass Winthrop Advisors, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 1,413 shares of MCK stock, worth $705,341. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,413
Previous 1,603 11.85%
Holding current value
$705,341
Previous $860,000 4.07%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$518.81 - $607.81 $98,573 - $115,483
-190 Reduced 11.85%
1,413 $825,000
Q1 2024

May 13, 2024

BUY
$473.42 - $539.26 $43,081 - $49,072
91 Added 6.02%
1,603 $860,000
Q4 2023

Feb 12, 2024

BUY
$437.42 - $470.64 $9,185 - $9,883
21 Added 1.41%
1,512 $700,000
Q4 2022

Feb 13, 2023

SELL
$346.68 - $397.58 $37,441 - $42,938
-108 Reduced 6.75%
1,491 $559,000
Q3 2022

Nov 15, 2022

SELL
$321.25 - $373.84 $22,808 - $26,542
-71 Reduced 4.25%
1,599 $543,000
Q2 2022

Aug 11, 2022

BUY
$300.57 - $336.42 $21,340 - $23,885
71 Added 4.44%
1,670 $545,000
Q1 2022

May 16, 2022

SELL
$244.61 - $310.48 $122,305 - $155,240
-500 Reduced 23.82%
1,599 $490,000
Q3 2021

Nov 10, 2021

BUY
$188.42 - $208.66 $20,349 - $22,535
108 Added 5.42%
2,099 $418,000
Q2 2021

Aug 02, 2021

BUY
$184.89 - $202.68 $39,936 - $43,778
216 Added 12.17%
1,991 $381,000
Q1 2021

May 13, 2021

BUY
$169.52 - $196.53 $300,898 - $348,840
1,775 New
1,775 $346,000
Q3 2018

Oct 12, 2018

SELL
$123.14 - $138.52 $195,176 - $219,554
-1,585 Closed
0 $0
Q2 2018

Jul 24, 2018

BUY
$133.4 - $158.13 $14,007 - $16,603
105 Added 7.09%
1,585 $211,000
Q4 2017

Feb 13, 2018

SELL
$135.02 - $162.6 $16,607 - $19,999
-123 Reduced 7.67%
1,480 $231,000
Q3 2017

Nov 13, 2017

BUY
$146.0 - $161.87 $234,038 - $259,477
1,603
1,603 $0

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $71.7B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Douglass Winthrop Advisors, LLC Portfolio

Follow Douglass Winthrop Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.